Prab: CSV import

2025-03-05T22:58:48Z

CSV import

← Older revision		Revision as of 22:58, 5 March 2025
Line 1:		Line 1:
	{{Short description\|A dopamine prodrug used in the treatment of heart failure}}		{{Short description\|A dopamine prodrug used in the treatment of heart failure and other conditions}}
	~~{{Drugbox~~
	~~\| verifiedfields = changed~~
	~~\| verifiedrevid = 477318123~~
	~~\| IUPAC_name = (2S)-2-[(3,4-dihydroxyphenyl)methylamino]propanoic acid~~
	~~\| image = Docarpamine.svg~~
	~~\| image_size = 200px~~
	~~\| image_alt = Structural formula of docarpamine~~
	}}

	'''Docarpamine''' is a [[prodrug]] of [[dopamine]], primarily used in the treatment of [[heart failure]]. It is designed to enhance the bioavailability of dopamine ~~by improving its absorption and distribution in~~ the ~~body~~.		[[File:Docarpamine.svg\|Chemical structure of Docarpamine\|thumb\|right]]

			'''Docarpamine''' is a [[prodrug]] of [[dopamine]], primarily used in the treatment of [[heart failure]] and other conditions where increased dopaminergic activity is desired. It is designed to enhance the bioavailability of dopamine when administered orally, overcoming the limitations of direct dopamine administration.

	==Pharmacology==		==Pharmacology==
	Docarpamine is metabolized in the body to release [[dopamine]], a neurotransmitter ~~that~~ plays a significant role in ~~the regulation of~~ cardiovascular functions. ~~Dopamine acts~~ on [[dopamine receptors~~]] in the heart and kidneys~~, ~~leading to increased~~ cardiac output and ~~improved~~ renal perfusion~~. This makes docarpamine useful~~ in ~~managing~~ conditions ~~where enhanced cardiac function is desired~~.		Docarpamine is metabolized in the body to release dopamine, which then exerts its effects by stimulating [[dopamine receptors]]. Dopamine is a key neurotransmitter in the [[central nervous system]] and plays a significant role in regulating [[cardiovascular]] and [[renal]] functions. By acting on dopamine receptors, docarpamine can improve cardiac output and renal perfusion, making it beneficial in conditions like heart failure.

	==Mechanism of Action==		==Mechanism of Action==
	~~The primary mechanism of action of~~ docarpamine ~~involves its~~ conversion to dopamine~~, which~~ then ~~exerts its effects by stimulating [[beta-adrenergic~~ receptors]] and ~~[[dopaminergic receptors]]~~. This ~~stimulation results~~ in ~~increased heart rate and contractility, as well as vasodilation, which helps to reduce~~ the workload on the heart and ~~improve blood flow to vital organs~~.		As a prodrug, docarpamine itself is not active. Once ingested, it undergoes enzymatic conversion in the body to release dopamine. The released dopamine then binds to dopamine receptors, particularly the D1 and D2 subtypes, leading to vasodilation and increased renal blood flow. This action helps in reducing the workload on the heart and improving symptoms of heart failure.

	==Clinical ~~Use~~==		==Clinical Uses==
	Docarpamine is used in the management of ~~[[chronic~~ heart failure]], ~~where it helps~~ to improve ~~symptoms by enhancing~~ cardiac ~~output~~. It ~~is particularly beneficial~~ in ~~patients who require~~ increased ~~cardiac performance without the adverse effects associated with direct~~ dopamine ~~administration.~~		Docarpamine is used in the management of heart failure, particularly in patients who require enhanced dopaminergic activity to improve cardiac function. It may also be used in other conditions where increased dopamine activity is beneficial, such as certain types of [[shock]] or [[renal failure]].

	~~==Administration==~~
	~~Docarpamine~~ is ~~administered orally~~, ~~and its dosage is adjusted based on the patient's response and clinical condition. The prodrug formulation allows for more consistent plasma levels~~ of ~~dopamine, reducing the need for frequent dosing~~.

	==Side Effects==		==Side Effects==
	~~Common~~ side effects of docarpamine include [[nausea]], [[headache]], and [[~~dizziness~~]]. ~~As with other dopaminergic agents~~, ~~there is a risk of~~ [[~~arrhythmias~~]] ~~and~~ [[~~hypotension~~]]~~, particularly at higher doses. Patients should be monitored for these adverse effects during treatment~~.		The side effects of docarpamine are primarily related to its dopaminergic activity. Common side effects include [[nausea]], [[vomiting]], [[headache]], and [[tachycardia]]. In some cases, patients may experience [[hypotension]] or [[arrhythmias]].

	==~~Related Compounds~~==		==Administration==
	Docarpamine is ~~related to other dopamine prodrugs and analogs, such as [[levodopa]]~~, which is ~~used in the treatment of [[Parkinson's disease]]. These compounds share a similar mechanism of action but differ in their clinical applications and pharmacokinetic profiles.~~		Docarpamine is administered orally, which is an advantage over direct dopamine administration that typically requires intravenous delivery. This makes it more convenient for outpatient management of chronic conditions.

	~~==Research and Development==~~
	~~Research into docarpamine and similar compounds continues, with a focus on improving their efficacy and safety profiles~~. ~~Studies are also exploring the potential use~~ of ~~docarpamine in other~~ conditions ~~where dopaminergic stimulation may be beneficial~~.

	==Related pages==		==Related pages==
	* [[Dopamine]]		* [[Dopamine receptor]]
	* [[Heart failure]]		* [[Heart failure]]
	* [[Prodrug]]		* [[Prodrug]]
	* [[~~Beta-adrenergic receptor~~]]		* [[Cardiovascular system]]

			[[Category:Prodrugs]]
			[[Category:Dopamine receptor agonists]]
	[[Category:Cardiovascular drugs]]		[[Category:Cardiovascular drugs]]
	~~[[Category:Dopamine agents]]~~

Prab: CSV import

2025-03-05T06:43:58Z

CSV import

New page

{{Short description|A dopamine prodrug used in the treatment of heart failure}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477318123
| IUPAC_name = (2S)-2-[(3,4-dihydroxyphenyl)methylamino]propanoic acid
| image = Docarpamine.svg
| image_size = 200px
| image_alt = Structural formula of docarpamine
}}

'''Docarpamine''' is a [[prodrug]] of [[dopamine]], primarily used in the treatment of [[heart failure]]. It is designed to enhance the bioavailability of dopamine by improving its absorption and distribution in the body.

==Pharmacology==
Docarpamine is metabolized in the body to release [[dopamine]], a neurotransmitter that plays a significant role in the regulation of cardiovascular functions. Dopamine acts on [[dopamine receptors]] in the heart and kidneys, leading to increased cardiac output and improved renal perfusion. This makes docarpamine useful in managing conditions where enhanced cardiac function is desired.

==Mechanism of Action==
The primary mechanism of action of docarpamine involves its conversion to dopamine, which then exerts its effects by stimulating [[beta-adrenergic receptors]] and [[dopaminergic receptors]]. This stimulation results in increased heart rate and contractility, as well as vasodilation, which helps to reduce the workload on the heart and improve blood flow to vital organs.

==Clinical Use==
Docarpamine is used in the management of [[chronic heart failure]], where it helps to improve symptoms by enhancing cardiac output. It is particularly beneficial in patients who require increased cardiac performance without the adverse effects associated with direct dopamine administration.

==Administration==
Docarpamine is administered orally, and its dosage is adjusted based on the patient's response and clinical condition. The prodrug formulation allows for more consistent plasma levels of dopamine, reducing the need for frequent dosing.

==Side Effects==
Common side effects of docarpamine include [[nausea]], [[headache]], and [[dizziness]]. As with other dopaminergic agents, there is a risk of [[arrhythmias]] and [[hypotension]], particularly at higher doses. Patients should be monitored for these adverse effects during treatment.

==Related Compounds==
Docarpamine is related to other dopamine prodrugs and analogs, such as [[levodopa]], which is used in the treatment of [[Parkinson's disease]]. These compounds share a similar mechanism of action but differ in their clinical applications and pharmacokinetic profiles.

==Research and Development==
Research into docarpamine and similar compounds continues, with a focus on improving their efficacy and safety profiles. Studies are also exploring the potential use of docarpamine in other conditions where dopaminergic stimulation may be beneficial.

==Related pages==
* [[Dopamine]]
* [[Heart failure]]
* [[Prodrug]]
* [[Beta-adrenergic receptor]]

[[Category:Cardiovascular drugs]]
[[Category:Dopamine agents]]

Docarpamine - Revision history

Prab: CSV import

Prab: CSV import